Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to SARS-CoV-2 vaccines in Finnish Defence Forces
2021-003686-36Phase 4Completed
- Sponsor
- Finnish Defence Forces
- Start
- Jul 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of SARS-CoV-2 vaccines in coronavirus disease 2019 (COVID-19), sponsored by Finnish Defence Forces. Primary endpoint: Immune response induced by SARS-CoV-2 vaccination. Started Jul 2021; status: completed.
02
Drugs
SARS-CoV-2 vaccines
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-003686-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003686-36.